Decreased Risk of Reduced Linear Growth Among Children with Atopic Dermatitis Receiving Dupilumab: A Cohort Study

Atopic Dermatitis

The real-world, long-term risk of infections associated with dupilumab in atopic dermatitis: A global cohort study

J Eur Acad Dermatol Venereol

Kridin K, Abdelghaffar M, Bieber K, Thaci D, Ludwig RJ

doi: 10.1111/jdv.20724

Atopic Dermatitis

The Risk of Venous Thromboembolism in Atopic Dermatitis: A Population-Based Cohort Study

Br J Dermatol

Ivert LU, Anveden-Berglind I, Gembert K, Eriksson J, Giunta DH, Hägg D, Linder M

doi: 10.1093/bjd/ljaf418

Atopic Dermatitis

Cardiovascular and thromboembolic risks of JAK inhibitors in atopic dermatitis: A global cohort study

J Eur Acad Dermatol Venereol

Kridin K, Kridin S, Mayer E, Sawaed W, Ludwig RJ

doi: 10.1111/jdv.20864

Atopic Dermatitis

Psoriasis Risk in Patients With Atopic Dermatitis Treated With Dupilumab

JAMA Dermatol

Lin TL, Fan YH, Fan KS, Juan CK, Chen YJ, Wu CY

doi: 10.1001/jamadermatol.2025.1578

Atopic Dermatitis

Risk of Developing Pediatric Uveitis Among Patients With Early-Onset Atopic Dermatitis

JAMA Ophthalmol

Chu YY, Sung CH, Lin YS, Ho CH, Chen YC, Lee WA, Kuo SC

doi: 10.1001/jamaophthalmol.2025.0366

Atopic Dermatitis

Dupilumab treatment in children aged 6 months to 5 years with severe atopic dermatitis

J Eur Acad Dermatol Venereol

Lasek A, Bellon N, Mallet S, Aubert H, Vera C, Achour L, Thénié C, Prescilla R, Abasq-Thomas C, Barbarot S

doi: 10.1111/jdv.70268

Atopic Dermatitis

Examining the Impact of Child Atopic Dermatitis on Maternal Depression: A Longitudinal Cohort Study

J Am Acad Dermatol

Kang HE, Lee A, Wang SP, Ye M, Capozza K, Ellis AW, Fox A, LeWinn KZ, Abuabara K

doi: 10.1016/j.jaad.2025.10.019

Psoriasis

GLP-1RA and reduced mortality, cardiovascular and psychiatric risks in psoriasis: a large-scale cohort study

Br J Dermatol

Olbrich H, Kridin K, Zirpel H, Hernandez G, Sadik CD, Gaffal E, Thaçi D, Ludwig RJ

doi: 10.1093/bjd/ljaf346

Atopic Dermatitis

Risk Factors for Moderate-Severe Asthma In Children Ages 5-11 Years with Early-onset Atopic Dermatitis

J Allergy Clin Immunol Pract

Zeiger RS, Schatz M, Zhou B, Stern JA, Li Q, Stanford RH, Shams M, Avella H, Subramaniam A, Chen W

doi: 10.1016/j.jaip.2025.07.036

Related content

The real-world, long-term risk of infections associated with dupilumab in atopic dermatitis: A global cohort study

The Risk of Venous Thromboembolism in Atopic Dermatitis: A Population-Based Cohort Study

Cardiovascular and thromboembolic risks of JAK inhibitors in atopic dermatitis: A global cohort study

Psoriasis Risk in Patients With Atopic Dermatitis Treated With Dupilumab

Risk of Developing Pediatric Uveitis Among Patients With Early-Onset Atopic Dermatitis

Dupilumab treatment in children aged 6 months to 5 years with severe atopic dermatitis

Examining the Impact of Child Atopic Dermatitis on Maternal Depression: A Longitudinal Cohort Study

GLP-1RA and reduced mortality, cardiovascular and psychiatric risks in psoriasis: a large-scale cohort study

Risk Factors for Moderate-Severe Asthma In Children Ages 5-11 Years with Early-onset Atopic Dermatitis